V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220004964 | 220001950 | 1.74 | 58 | Palliative (P) | 2015-12-29 | 2015-12-29 | Trial Unspecified | Y | N | 220027169 | TRIAL |
| 220004965 | 220001950 | 1.74 | null | Palliative (P) | null | 2016-08-17 | CYTARABINE | 02 | N | 220027169 | CYTARABINE |
| 220004966 | 220001950 | null | 72 | Not known (9) | 2016-05-06 | 2016-05-06 | AML17 TRIAL | null | null | 220027169 | AML17 TRIAL |
| 220004967 | 220001950 | null | 69.9 | Curative (C) | null | 2013-09-09 | AML17 TRIAL | null | null | 220027169 | AML17 TRIAL |
| 220004968 | 220001950 | null | 80 | Disease modification (D) | 2015-11-18 | 2016-02-22 | Trial Unspecified | Y | N | 220027169 | TRIAL |
| 220004969 | 220001950 | null | null | Palliative (P) | 2013-08-28 | 2013-08-28 | Cytarabine low (10to20mg/m2) IV/SC | 2 | N | 220027169 | CYTARABINE |
| 220004970 | 220001951 | null | 61.5 | Not known (9) | 2013-12-05 | 2013-12-14 | CYTARABINE | N | N | 220027184 | CYTARABINE |
| 220004971 | 220001951 | 1.7 | 71.5 | Curative (C) | null | 2015-02-15 | Trial Unspecified | N | N | 220027184 | TRIAL |
| 220004972 | 220001951 | null | null | Disease modification (D) | 2015-12-04 | 2015-12-09 | Cytarabine Low Dose | 02 | N | 220027184 | CYTARABINE |
| 220004973 | 220001952 | 1.65 | 94.1 | Curative (C) | 2013-10-14 | 2013-10-14 | Trial Unspecified | Y | N | 220027192 | TRIAL |
| 220004974 | 220001953 | 1.48 | 62.7 | null | 2013-12-16 | 2013-12-19 | Cytarabine low (10to20mg/m2) IV/SC | N | N | 220027194 | CYTARABINE |
| 220004975 | 220001953 | 1.65 | 62.4 | Curative (C) | 2016-10-29 | 2016-10-29 | AML17 TRIAL | 1 | null | 220027194 | AML17 TRIAL |
| 220004976 | 220001954 | null | 68 | Curative (C) | 2015-02-18 | 2015-04-08 | Cytarabine Low Dose | 02 | N | 220027199 | CYTARABINE |
| 220004977 | 220001955 | 1.83 | 119.5 | Palliative (P) | 2017-05-15 | 2017-05-17 | Trial Unspecified | Y | N | 220027200 | TRIAL |
| 220004978 | 220001956 | null | 88.6 | Curative (C) | 2016-11-18 | 2016-11-18 | AML17 TRIAL | N | N | 220027201 | AML17 TRIAL |
| 220004979 | 220011020 | 1.58 | 69.8 | Curative (C) | 2014-06-02 | 2014-06-03 | AML17 TRIAL | 01 | null | 220027204 | AML17 TRIAL |
| 220004980 | 220001957 | 1.7 | null | null | 2013-12-28 | 2013-12-28 | Cytarabine Low Dose | N | N | 220027205 | CYTARABINE |
| 220004983 | 220001958 | 1.83 | null | Palliative (P) | 2015-01-28 | 2015-01-29 | Cytarabine Low Dose | 2 | N | 220027212 | CYTARABINE |
| 220004984 | 220001958 | 1.7 | 63.3 | null | null | 2015-11-23 | Cytarabine Low Dose | 02 | N | 220027212 | CYTARABINE |
| 220004985 | 220001958 | 1.79 | 0 | Palliative (P) | 2015-09-13 | 2015-09-16 | CYTARABINE | null | null | 220027212 | CYTARABINE |
| 220004986 | 220001959 | null | 87.6 | Radical (R) | 2013-12-03 | 2013-12-05 | AML17 TRIAL | 1 | null | 220027215 | AML17 TRIAL |
| 220004987 | 220001959 | 1.56 | null | Curative (C) | 2013-06-05 | 2013-06-05 | AML17 TRIAL | N | N | 220027215 | AML17 TRIAL |
| 220004988 | 220001959 | null | null | Curative (C) | 2013-05-31 | 2013-05-31 | AML17 TRIAL | 1 | null | 220027215 | AML17 TRIAL |
| 220004989 | 220001960 | 1.66 | 98 | Adjuvant (A) | 2015-09-10 | 2015-09-25 | AML17 TRIAL | N | N | 220027219 | AML17 TRIAL |
| 220004990 | 220001960 | 1.78 | null | null | 2016-04-24 | 2016-05-04 | Cytarabine Low Dose | 99 | N | 220027219 | CYTARABINE |
| 220004991 | 220001960 | null | 79.8 | Curative (C) | 2016-10-08 | 2017-03-16 | Cytarabine Low Dose | N | N | 220027219 | CYTARABINE |
| 220004992 | 220001960 | null | 64.3 | Disease modification (D) | 2017-05-31 | 2017-05-31 | Cytarabine Low Dose | 2 | N | 220027219 | CYTARABINE |
| 220004993 | 220020301 | 1.62 | 55 | null | 2016-10-29 | 2016-10-29 | AML17 TRIAL | 01 | N | 220027227 | AML17 TRIAL |
| 220004994 | 220001961 | null | 77 | Palliative (P) | null | 2016-11-30 | LI-1 TRIAL | null | null | 220027228 | TRIAL |
| 220004995 | 220001961 | 1.77 | null | Palliative (P) | 2014-04-05 | 2014-04-10 | Cytarabine Low Dose | N | N | 220027228 | CYTARABINE |
| 220004996 | 220001961 | 1.8 | 91 | Curative (C) | 2016-12-26 | 2016-12-27 | Trial Unspecified | Y | N | 220027228 | TRIAL |
| 220005001 | 220001963 | 1.78 | 77 | Curative (C) | 2012-08-14 | 2013-04-24 | AML17 TRIAL | N | N | 220027247 | AML17 TRIAL |
| 220005002 | 220001963 | 1.79 | null | Not known (9) | 2014-07-16 | 2014-07-16 | AML17 TRIAL | N | N | 220027247 | AML17 TRIAL |
| 220005003 | 220001964 | null | 86.1 | null | 2013-12-01 | 2013-12-01 | Cytarabine low (10to20mg/m2) IV/SC | N | N | 220027251 | CYTARABINE |
| 220005004 | 220001965 | 1.77 | 67.5 | null | 2015-01-06 | 2015-01-06 | Trial Unspecified | 01 | null | 220027252 | TRIAL |
| 220005005 | 220001965 | 1.69 | null | Curative (C) | 2013-09-28 | 2013-09-28 | AML17 TRIAL | Y | N | 220027252 | AML17 TRIAL |
| 220005006 | 220001965 | 1.65 | null | Palliative (P) | null | 2017-08-13 | CYTARABINE | null | null | 220027252 | CYTARABINE |
| 220005007 | 220001965 | 1.69 | 45.4 | Disease modification (D) | 2014-06-05 | 2014-06-05 | LI-1 TRIAL | 01 | N | 220027252 | TRIAL |
| 220005008 | 220001966 | 0 | 58.4 | Curative (C) | 2017-01-29 | 2017-01-29 | AML17 TRIAL | 01 | null | 220027260 | AML17 TRIAL |
| 220005009 | 220011029 | 1.78 | 67.8 | Not known (9) | 2017-03-31 | 2017-04-01 | AML17 TRIAL | 02 | N | 220027261 | AML17 TRIAL |
| 220005010 | 220011029 | null | 0 | Curative (C) | 2015-05-22 | 2015-05-28 | LI-1 TRIAL | Y | N | 220027261 | TRIAL |
| 220005011 | 220001967 | 1.6 | 0 | Palliative (P) | 2015-02-09 | 2015-02-20 | Trial Unspecified | 01 | N | 220027263 | TRIAL |
| 220005012 | 220001967 | 1.7 | 81 | null | 2017-12-09 | 2017-12-09 | Cytarabine low (10to20mg/m2) IV/SC | N | N | 220027263 | CYTARABINE |
| 220005017 | 220001969 | null | null | null | null | 2013-04-03 | CYTARABINE | null | null | 220027280 | CYTARABINE |
| 220005018 | 220001969 | 1.48 | null | Palliative (P) | 2016-01-13 | 2016-01-13 | CYTARABINE | N | N | 220027280 | CYTARABINE |
| 220005019 | 220001970 | 1.56 | 60 | Curative (C) | null | 2013-06-21 | AML17 TRIAL | null | null | 220027283 | AML17 TRIAL |
| 220005020 | 220001971 | 1.75 | 83 | Disease modification (D) | 2015-07-25 | 2015-07-25 | Trial Unspecified | Y | N | 220027289 | TRIAL |
| 220005021 | 220001971 | null | null | Curative (C) | 2014-05-01 | 2014-05-02 | AML17 TRIAL | 1 | N | 220027289 | AML17 TRIAL |
| 220005022 | 220001972 | 1.57 | 0 | Adjuvant (A) | 2015-04-02 | 2015-04-02 | Trial Unspecified | Y | N | 220027295 | TRIAL |
| 220005023 | 220001973 | 1.72 | null | Curative (C) | 2017-04-08 | 2017-04-08 | AML17 TRIAL | N | N | 220027297 | AML17 TRIAL |